Where does Pediatrix Medical Group's income statement data come from?

Every line is extracted from Pediatrix Medical Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$1.93B-2.3%	$1.91B-4.9%	$1.92B-4.2%	$1.94B-3.1%	$1.98B-1.1%
General and administrative	$242.45M+2.4%	$240.79M+1.0%	$238.66M+4.7%	$235.99M+3.9%	$236.84M+3.6%
Depreciation and amortization	$22.61M-17.0%	$21.83M-32.3%	$23.07M-33.0%	$23.77M-36.4%	$27.25M-27.4%
Restructuring charges	$20.59M-67.0%	$22.27M-65.3%	$40.03M-6.5%	$52.64M+117%	$62.39M+483%
Goodwill impairment	——	——	——	——	——
Impairment charges	——	——	——	——	——
Other operating expenses	$1.71B-15.5%	$1.71B-18.1%	$1.72B-22.6%	$1.78B-19.9%	$2.03B+1.2%
Total operating expenses	$1.71B-15.5%	$1.71B-18.1%	$1.72B-22.6%	$1.78B-19.9%	$2.03B+1.2%
Operating income	$218.37M—	$208.81M—	——	——	——
Operating margin	11.3%—	10.9%—	——	——	——
Interest expense	$35.08M-10.7%	$35.97M-11.7%	$36.94M-10.2%	$38.12M-7.8%	$39.3M-7.1%
Interest income	$19.07M+124%	$19.05M+230%	$17.18M+231%	$12.38M+184%	$8.5M+48.6%
Other income (expense), net	——	——	$4.86M+109%	-$23.46M+57.2%	-$28.57M+47.5%
Gain (loss) on disposal of assets	——	$0—	——	——	——
Income before income taxes	$227.19M—	$216.43M—	——	——	——
Income tax expense	$52.96M—	$51.04M—	——	——	——
Net income	$174.22M—	$165.39M—	——	——	——
Net margin	9%—	8.6%—	——	——	——
Diluted earnings per share	$2.06—	$1.94—	——	——	——
Basic earnings per share	$2.09—	$1.97—	——	——	——
Weighted-average shares, diluted	339.6M+0.9%	342M+2.3%	339.9M+2.0%	338.8M+2.1%	336.6M+1.7%
Weighted-average shares, basic	334.7M-0.1%	338.3M+1.5%	337.2M+1.5%	336.5M+1.7%	335M+1.5%
Practice Salaries And Benefits	$1.35B-4.2%	$1.34B-6.9%	$1.34B-7.8%	$1.37B-5.8%	$1.41B-3.2%
Practice Supplies And Other Operating Expenses	$78.07M-25.9%	$79.27M-32.7%	$84.35M-32.3%	$93.59M-26.0%	$105.35M-15.8%
Amortization Of Financing Costs And Discounts	$808K-17.9%	$935K-2.0%	$949K+2.4%	$972K+2.7%	$984K-5.9%
Net cash provided by operating activities from the Prepaid Business	-$2.64M+72.0%	-$3.65M+65.8%	-$4.94M+60.9%	-$8M+19.4%	-$9.43M+15.0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$174.59M—	$167.07M—	——	——	——
Deferred taxes	$56.13M—	$52.19M—	——	——	——
Accounts payable and other current liabilities	——	——	——	——	——
Increase (Decrease) in Accounts Receivable	-$17.96M+52.3%	-$30.56M-197%	-$38.76M-705%	-$32.46M—	-$37.69M—
Loss and loss adjustment expense reserves	-$2.94M-152%	-$9.42M-154%	-$4.1M—	$1.1M—	$5.63M—
Increase (decrease) in other assets	-$21.89M+32.6%	-$21.8M+35.4%	-$20.13M+49.8%	-$26.37M+24.1%	-$32.48M-16.8%
Other liabilities	-$25.48M-7.0%	-$26.07M-14.9%	-$13.27M+61.0%	-$20.37M+31.6%	-$23.82M+18.7%
Increase (Decrease) in Prepaid Expense and Other Assets	$1.76M—	$2.92M—	——	——	——
Net interest and investment income (loss)	$19.07M+124%	$19.05M+230%	$17.18M+231%	$12.38M+184%	$8.5M+48.6%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$129.09M-33.5%	-$107.49M-642%	-$43.82M-207%	-$18.33M+70.3%	-$96.72M-66.5%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	——	——	——	-$20.89M+62.4%	-$26.63M+49.8%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$258.71M+20.7%	$271.09M+31.2%	$290M+103%	$244.55M+86.8%	$214.34M+89.7%
Net Cash Provided By Used In Operating Activities Continuing Operations	$261.35M+16.8%	$274.74M+26.5%	$294.94M+89.7%	$252.55M+79.3%	$223.76M+80.3%
Other Noncash Income (Expense)	$4.47M+81.5%	$4.56M+53.5%	$4.35M+22.0%	$2.8M-29.2%	$2.47M-39.0%
Payment for (Proceeds from) Other Investing Activity	——	——	——	——	-$3.15M-420%
Payments for Repurchase of Common Stock	$106.57M+4,368%	$86.68M+4,990%	$23.29M+2,097%	$2.58M+151%	$2.39M+131%
Payments to Acquire Businesses, Net of Cash Acquired	$30.2M—	$23.2M—	——	——	——
Payments to Acquire Investments	$29.1M-47.5%	$29.85M-53.8%	$33.63M-43.8%	$46.16M-14.6%	$55.41M+41.2%
Proceeds from Issuance of Common Stock	$3.07M-10.9%	$3.18M-12.5%	$3.27M-17.0%	$3.47M-18.1%	$3.44M-26.4%
Financing — other	——	——	-$75K—	——	——
Stock-based compensation	$19.07M+53.2%	$18.05M+52.0%	$15.44M+27.0%	$14.4M+28.5%	$12.44M+0.5%
Unrealized Gain Loss On Investments	$369K—	$1.68M—	——	——	——
EBIT	$218.37M—	$208.81M—	——	——	——
EBITDA	$240.98M—	$230.64M—	——	——	——
EBITDA	$240.98M—	$230.64M—	——	——	——
EBITDA margin	12.5%—	12.1%—	——	——	——
EBIT	$218.37M—	$208.81M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Pediatrix Medical Group's income statement data come from?: Every line is extracted from Pediatrix Medical Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.